A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and German partner BioNTech said Friday. Read more
Tag: BioNTech
Pfizer and BioNTech report positive data in trial of omicron-targeting bivalent booster in individuals aged 18 and older
Pfizer Inc. PFE, +0.26% and German partner BioNTech SE BNTX, +5.53% said Thursday early data from a Phase 2/3 clinical trial of their omicron BA.4/BA.5-adapated bivalent booster showed positive results Read more
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for their omicron-targeting bivalent vaccine for use in children 5 to 11 years of age. The Read more
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for their omicron-targeting bivalent vaccine for use in children 5 to 11 years of age. The Read more
Vaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over
Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with “60 Minutes” that aired on Sunday. Moderna Read more
Report finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents
Some 16 million Americans of working age have long-term COVID and as many as 4 million are not working as they struggle with their symptoms, according to a new report from Read more
Moderna sues Pfizer and BioNTech for patent infringement relating to the mRNA platform used to develop COVID vaccines
Moderna Inc. MRNA, -1.49% said Friday it is suing Pfizer Inc. PFE, -1.06% and German partner BioNTech SE BNTX, -2.27% for infringing patents relating to its mRNA platform, the source Read more
Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day, according to a new report. The New York Times reported Tuesday night that the Biden administration Read more
Pfizer and BioNTech say data show COVID vaccine has more than 70% efficacy in small children, with cases now rising in just 7 states
Pfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in children 6 months to 4 years old. The companies PFE, -2.07% BNTX, +0.07% said updated Read more
BioNTech stock sinks more than 8% after profit, revenue fall below expectations
The U.S.-listed shares of Germany-based BioNTech SE BNTX, +1.48% sank 8.2% in premarket trading Monday, after the biotechnology company and Pfizer Inc. PFE, -1.18% partner in developing a COVID-19 vaccine Read more